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he modulation of Ca
 
2
 
 
 
 signaling patterns during repet-
itive stimulations represents an important mechanism
for integrating through time the inputs received by
a cell. By either overexpressing the isoforms of protein
kinase C (PKC) or inhibiting them with speciﬁc blockers,
we investigated the role of this family of proteins in regulating
the dynamic interplay of the intracellular Ca
 
2
 
 
 
 pools. The
effects of the different isoforms spanned from the reduction
of ER Ca
 
2
 
 
 
 release (PKC
 
 
 
) to the increase or reduction of
T
 
mitochondrial Ca
 
2
 
 
 
 uptake (PKC
 
 
 
 and PKC
 
 
 
/PKC
 
 
 
, respec-
tively). This PKC-dependent regulatory mechanism underlies
the process of mitochondrial Ca
 
2
 
 
 
 desensitization, which
in turn modulates cellular responses (e.g., insulin secretion).
These results demonstrate that organelle Ca
 
2
 
 
 
 homeostasis
(and in particular mitochondrial processing of Ca
 
2
 
 
 
 signals)
is tuned through the wide molecular repertoire of intracel-
lular Ca
 
2
 
 
 
 transducers.
 
Introduction
 
PKC comprises a family of serine/threonine protein kinases,
which participate in transducing intracellularly a wide number
of extracellular signals (Mellor and Parker, 1998). They have
been shown to participate in signaling events as diverse as
cell proliferation, apoptosis, smooth muscle contraction, and
secretion (Dekker and Parker, 1994; Toker, 1998). Up to 12
distinct family members have been discovered in mammalian
cells. They have been subdivided into three classes: (1) the
classical or conventional PKCs (
 
 
 
, 
 
 
 
I, 
 
 
 
II, and 
 
 
 
) activated
by Ca
 
2
 
 
 
 and diacylglycerol; (2) the new or novel PKCs (
 
 
 
, 
 
 
 
,
 
 
 
, and 
 
 
 
) activated by diacylglycerol but Ca
 
2
 
 
 
 independent;
and (3) the atypical PKCs (
 
 
 
 and 
 
 
 
), which are Ca
 
2
 
 
 
 and
diacylglycerol insensitive (Nishizuka, 1992).
On the one hand, Ca
 
2
 
 
 
 is a crucial activator of some PKC
isoforms; on the other hand, PKC-dependent phosphoryla-
tion reactions have been shown to modify the spatio-tem-
poral pattern of cellular Ca
 
2
 
 
 
 responses. Indeed, PKCs were
shown to differentially decode high and low frequency Ca
 
2
 
 
 
spiking (Oancea and Meyer, 1998) and to modulate Ca
 
2
 
 
 
release from the ER evoked by agonist stimulation (Montero
et al., 2003). Thus, they appear to be an important part of
the molecular machinery underlying the wide complexity of
Ca
 
2
 
 
 
 signaling (Pozzan et al., 1994; Clapham, 1995; Berridge
et al., 2000). As the site of action, much remains to be explored.
Indeed, PKCs were shown to associate to cellular domains and
organelles playing a crucial role in generating and decoding
Ca
 
2
 
 
 
 signals, such as the plasma membrane, the ER, the
Golgi apparatus, and the mitochondria (Goodnight et al.,
1995; Wang et al., 1999; Perego et al., 2002).
In this contribution, we took advantage of intracellularly
targeted Ca
 
2
 
 
 
 probes (the aequorin chimeras) and a panel of
PKC-GFP fusion proteins to explore the effects of the various
PKC isoforms on the Ca
 
2
 
 
 
 signals occurring in different
cellular domains. Specifically, we constructed a panel of
PKC-GFP chimeras that allow the molecular repertoire of
these effectors to be altered. The chimeras include the 
 
 
 
, 
 
 
 
,
 
 
 
, 
 
 
 
, and 
 
 
 
 isoforms (Chiesa et al., 2001). For measuring
Ca
 
2
 
 
 
 concentration, we used aequorin-based recombinant
probes (Rizzuto et al., 1992; Brini et al., 1995; Montero et
al., 1995; Pinton et al., 1998) that can be cotransfected with
the protein of interest, thus providing an accurate monitoring
of Ca
 
2
 
 
 
 signaling in the transfected subset of cells, and
probes that are specifically targeted to a defined subcellular
compartment, thus providing a complete analysis of intra-
cellular Ca
 
2
 
 
 
 homeostasis. In our work, we analyzed the
effects of the various isoforms on organelle Ca
 
2
 
 
 
 handling,
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with special focus on mitochondria. These organelles act as
an important “decoding station,” where Ca
 
2
 
 
 
 signals can ex-
ert effects as diverse as stimulation of aerobic metabolism
(Jouaville et al., 1999) and release of proapoptotic factors to
the cytoplasm (Kroemer and Reed, 2000).
By this means, we observed that the overexpression of dif-
ferent PKC isoforms induces specific alterations of cellular
Ca
 
2
 
 
 
 homeostasis. In particular, we observed an effect of
some isoforms on mitochondrial Ca
 
2
 
 
 
 responses. Then, we
addressed the mechanisms that allow this fine modulation of
mitochondrial Ca
 
2
 
 
 
 homeostasis and analyzed some possible
targets of PKC action, such as the mitochondrial membrane
potential (
 
  
 
m
 
; i.e., the driving force for the Ca
 
2
 
 
 
 uptake
into the organelle), the production of reactive oxygen species
(ROS), and the three-dimensional structure of the organelle.
Finally, we obtained evidence for the involvement of the 
 
 
 
isoform of PKC in the yet poorly understood phenomenon
of desensitization of mitochondrial Ca
 
2
 
 
 
 responses (Maech-
ler et al., 1998; Challet et al., 2001).
 
Results
 
Different effects of PKC isoforms on mitochondrial 
Ca
 
2
 
 
 
 signaling
 
The initial goal of our work was to evaluate whether or not
the various PKC isoforms could differently affect Ca
 
2
 
 
 
 han-
dling in mitochondria, which is an important site for decod-
ing cellular Ca
 
2
 
 
 
 signals. For this purpose, a defined PKC iso-
form was overexpressed through the panel of PKC-GFP
chimeras developed in the laboratory, and mitochondrial
Ca
 
2
 
 
 
 homeostasis was monitored through a cotransfected mi-
tochondrially targeted aequorin (AEQ) probe, mtAEQ. Spe-
cifically, HeLa cells were either cotransfected with the PKC-
GFP chimera of interest and mtAEQ (PKC overexpressing)
or transfected with mtAEQ alone (control). After transfection
and reconstitution of the photoprotein (see Materials and
methods for details), the coverslip with the transfected cells
was transferred to the luminometer chamber and data were
collected. In all cases, the mitochondrial Ca
 
2
 
 
 
 response to his-
tamine, an agonist acting on Gq-coupled receptor and caus-
ing the production of inositol 1,4,5 trisphosphate (IP3), was
investigated (Fig. 1). Both in control and PKC-transfected
cells, histamine stimulation caused a large, rapid rise in mito-
chondrial Ca
 
2
 
 
 
 concentration ([Ca
 
2
 
 
 
]
 
m
 
) that returned to al-
most basal levels in 
 
 
 
1 min. The effect of overexpressed PKC
isoforms on this [Ca
 
2
 
 
 
] response was different. In cells over-
expressing PKC
 
 
 
, the histamine-dependent [Ca
 
2
 
 
 
]
 
m
 
 rise was
almost unchanged (peak amplitude: 87 
 
 
 
 14 
 
 
 
M [PKC
 
 
 
] vs.
91 
 
 
 
 4 
 
 
 
M [control]; 
 
n
 
 
 
 
 
 18, P 
 
 
 
 0.05), indicating that the
alteration of mitochondrial Ca
 
2
 
 
 
 responses is not a general
feature of all PKCs. In contrast, in PKC
 
 
 
-, 
 
 
 
-, and 
 
 
 
-trans-
fected cells, the [Ca
 
2
 
 
 
]
 
m
 
 increases evoked by stimulation with
Figure 1. Mitochondrial Ca
2  homeo-
stasis in control and PKC-overexpressing 
HeLa cells. Parallel batches of HeLa cells 
were either cotransfected with mtAEQ 
and a PKC-GFP chimera including the 
indicated PKC isoform or transfected 
with mtAEQ alone (Control). 36 h after 
transfection, the measurement of AEQ 
luminescence was performed and cali-
brated into [Ca
2 ] values as described in 
Materials and methods. Where indicated, 
the cells were challenged with 100  M 
histamine. In this and in the following 
aequorin experiments, the traces are 
representative of at least 10 from 3 
independent experiments, which gave 
similar results.
Figure 2. Effects of PKC ,  , and   inhibitors on 
mitochondrial Ca
2  homeostasis. HeLa cells were 
transfected with the mtAEQ chimera. 16 h before the 
aequorin measurement (performed 36 h after transfec-
tion), the cells were treated with 10  M Ro-32-0432 
(PKC  inhibitor), 5  M hispidin (PKC  inhibitor), or 
50  M PKC  pseudosubstrate inhibitor myristoylated 
(PKC  inhibitor), as labeled. Where indicated, the cells 
were challenged with 100  M histamine. All other 
conditions were as in Fig. 1. Traces from control and 
inhibitor-treated cells are displayed in gray or black, 
respectively. 
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histamine were significantly smaller than in controls (peak
amplitude: 29   5  M [PKC ], 34   4  M [PKC ], and
43   8  M [PKC ]; n   11, P   0.05). On the contrary, in
cells overexpressing PKC , the [Ca
2 ] rise was markedly
larger (peak amplitude: 109   9  M; n   15, P   0.05).
To rule out the possibility that we were observing spurious
effects due to major overexpression of active kinases (and thus
a global perturbation of cellular functions), we aimed at con-
firming these observations in cells expressing only endogenous
kinases by using isoform-specific PKC inhibitors. The expec-
tation was to observe an effect opposite to that caused by the
recombinant overexpression of the kinase. In these experi-
ments, mtAEQ-expressing HeLa cells were treated 16 h be-
fore the Ca
2  measurements with 10  M Ro-32-0432 (Bir-
chall et al., 1994), 5  M hispidin (Gonindard et al., 1997), or
50  M PKC  pseudosubstrate inhibitor myristoylated (Sajan
et al., 1999) to inhibit endogenous PKC ,  , or  , respec-
tively (Fig. 2). [Ca
2 ]m responses to histamine stimulations
were evaluated as in Fig. 1. The results obtained well match
those obtained by overexpressing the different PKC isoforms.
Indeed, the inhibition of PKC  and   caused a significant in-
crease of the [Ca
2 ]m rise evoked by histamine (peak ampli-
tude: 152   14  M [PKC ] and 107   9  M [PKC ]; n  
7, P   0.05). Interestingly, the increase caused by the inhibi-
tors appears larger in the case of inhibition of PKC  than of
PKC  both in absolute terms and as a percent (77 vs. 21% in-
crease, respectively). These are fully specular results to the
overexpression experiments of PKC  and PKC , indicating a
more pronounced inhibitory effect of PKC . Vice versa the
inhibition of PKC  drastically reduced the [Ca
2 ]m rise (peak
amplitude: 66   4  M; n   11, P   0.05). The inhibition of
the PKC  (with Rottlerin) was not, in our hands, informative,
as the prolonged exposure to the inhibitor not only almost
abolished both cytosolic and mitochondrial Ca
2  responses
but also was associated to high cell mortality.
The analysis of intracellular calcium stores and 
of cytosolic Ca
2  responses indicates a specific 
mitochondrial effect for some PKC isoform
We investigated whether or not the [Ca
2 ]m changes were
paralleled by alterations of cytosolic Ca
2  signals. Indeed,
the mitochondrial Ca
2  response usually follows and ampli-
fies the agonist-dependent cytosolic rise. In the experiment
shown in Fig. 3 A, HeLa cells, either coexpressing the PKC
chimera of interest and cytosolic aequorin (PKC overex-
pressing) or expressing only cytosolic aequorin (control)
(Brini et al., 1995), were challenged with histamine. As ex-
pected based on mitochondrial results, there is no difference
in the cytosolic Ca
2  response between control and PKC -
overexpressing cells (peak amplitude: 2.6   0.1  M [PKC ]
vs. 2.6   0.1  M [control]; n   18, P   0.05). A signifi-
cant reduction of the response was observed in the PKC -
overexpressing cells (peak amplitude: 1.8   0.1  M; n  
12, P   0.05). Surprisingly, in contrast with the mitochon-
drial results, in the cytosolic compartment there is only a
small reduction in PKC - and PKC -overexpressing cells
(peak amplitude: 2.2   0.1  M; n   17, P   0.05 for
PKC  and 2.3   0.2  M; n   15, P   0.05 for PKC )
Figure 3. Cytosolic Ca
2  homeostasis in 
control and PKC-overexpressing HeLa 
cells. (A) Aequorin measurements: parallel 
batches of HeLa cells were either cotrans-
fected with cytAEQ and a PKC-GFP 
chimera including the indicated PKC 
isoform or transfected with the cytAEQ 
alone (Control). All other conditions were 
as in Fig. 1. Where indicated, the cells 
were challenged with 100  M histamine. 
(B) Relationship between cytosolic and 
mitochondrial Ca
2  responses: parallel 
batches of HeLa cells were transfected 
with either the cytAEQ or the mtAEQ 
chimera. All other conditions were as in 
Fig. 1. To reduce the [Ca
2 ]c and [Ca
2 ]m 
responses, the Ca
2  stores were partially 
depleted by preincubating the cells in 
KRB/EGTA for different periods (as 
indicated) before challenging them with 
100  M histamine. [Ca
2 ]c and [Ca
2 ]m 
responses are expressed as a percentage 
of the peak amplitude (compare with 
control, non-EGTA–pretreated cells). The 
inset highlights the condition in which 
the reduction of the [Ca
2 ]c response is 
the same of that observed on PKC over-
expression. (C) Fura-2 measurements: 
HeLa cells transfected with PKC -GFP or 
PKC -GFP (top) and loaded with fura-2 
were stimulated with 100  M histamine. 
The kinetic behavior of the [Ca
2 ]c 
response (bottom) is presented as a 340:
380 nm ratio.226 The Journal of Cell Biology | Volume 165, Number 2, 2004
and no difference was detected in PKC -overexpressing cells
(peak amplitude: 2.6   0.2  M; n   15, P   0.05).
Given the nonlinear dependence of mitochondrial Ca
2 
accumulation on [Ca
2 ]c, we could not rule out, in principle,
that the small reduction of the [Ca
2 ]c peak of PKC - and
PKC -expressing cells accounted for the large drop of the
[Ca
2 ]m response. To verify this possibility, we performed a
specific series of experiments, aimed at directly assessing the
correlation between the [Ca
2 ]c and [Ca
2 ]m responses. In
these experiments, [Ca
2 ]c was gradually reduced by incubat-
ing the cells in EGTA-containing, Ca
2 -free KRB (KRB/
EGTA) for variable time lengths before challenging them
with histamine. This process caused a progressively larger de-
crease in the histamine-induced [Ca
2 ]c peak, from 8% (after
5 min in KRB/EGTA) to 19% (after 50 min), and in the
[Ca
2 ]m peak, from 19% (after 5 min in KRB/EGTA) to
38% (after 50 min). It is apparent that for an  15% reduc-
tion of the [Ca
2 ]c peak (i.e., slightly larger than that ob-
served in PKC - and PKC -overexpressing cells), the de-
crease of the [Ca
2 ]m peak was  24% (compared with an
 63 and 53% reduction in PKC - and PKC -overexpress-
ing cells, respectively). We verified if the PKC isoforms could
alter the kinetics of the [Ca
2 ]c rise (an effect that could be
overlooked by the low temporal resolution of the aequorin
measurements). For this purpose, we performed single cell
fura-2 imaging studies, comparing the [Ca
2 ]c responses of
PKC -GFP– and PKC -GFP–transfected cells (identified
by the GFP moiety) with those of nontransfected cells. Rep-
resentative cells and traces are shown in Fig. 3 C; in this and
similar experiments, no difference could be detected between
PKC  (or PKC )-transfected and control cells in either the
kinetics or the peak value of the histamine-induced [Ca
2 ]c
rise. Overall, these experiments indicate that no major feature
of cytosolic Ca
2  signaling is significantly affected by the
overexpression of these PKC isoforms; thus, the major reduc-
tion of the [Ca
2 ]c responses must be ascribed to a direct ef-
fect on mitochondrial Ca
2  homeostasis.
To confirm the latter conclusion, we also investigated the
effect of PKC overexpression on the agonist-sensitive Ca
2 
stores. Although the key parameter for mitochondrial Ca
2 
uptake (the [Ca
2 ]c transient) was unaffected, we wanted to
exclude the possibility that ER loading (or its discharge
properties) was affected by the activity of the PKC isoforms,
an effect that could have a greater impact on [Ca
2 ]m than
[Ca
2 ]c. Indeed, in a recent paper, by altering ER Ca
2  levels
through overexpression of SERCA (sarco-ER Ca
2  ATPase)
or plasma membrane Ca
2  ATPase, Brini et al. (2000)
showed that mitochondrial Ca
2  responses correlate with
the state of filling of the Ca
2  stores and the rate and extent
of Ca
2  release rather than with the [Ca
2 ] rise detected in
the bulk cytosol (Brini et al., 2000).
Thus, we monitored the [Ca
2 ] of agonist-sensitive Ca
2 
stores, using the aequorin chimeras targeted to the endoplas-
mic reticulum (erAEQ; Montero et al., 1995) or to the
Golgi apparatus (GoAEQ; Pinton et al., 1998). For this pur-
pose, HeLa cells were either cotransfected with the PKC chi-
mera of interest and erAEQ (or GoAEQ; PKC-overexpress-
ing) or transfected with erAEQ (or GoAEQ) alone (control;
see Materials and methods). Figs. 4 and 5 show the cali-
brated [Ca
2 ] values in the two compartments. To obtain
reliable quantitative estimates of the [Ca
2 ] in the lumen of
these two organelles, their [Ca
2 ] needs to be decreased dur-
ing both the reconstitution of aequorin with coelenterazine
and the subsequent initial phase of perfusion with KRB/
EGTA in the luminometer (see Materials and methods).
Under those conditions, the [Ca
2 ] was  10  M in both
organelles. When the [Ca
2 ] in the perfusion medium was
switched to 1 mM, the [Ca
2 ] in the lumen of the two com-
partments gradually increased. The [Ca
2 ] in the lumen of
the two compartments, in control cells, reached a plateau
value of 419   10  M (n   39) in the ER and 228   8
 M (n   27) in the Golgi apparatus. In PKC-transfected
cells, Ca
2  was reaccumulated in the organelles with a simi-
lar time course, and comparable steady-state values were at-
tained in both compartments (ER: 392   7  M [PKC ],
417   8  M [PKC ], 399   6  M [PKC ], 386   10
 M [PKC ], and 424   8  M [PKC ]; n   10, P   0.05;
Golgi apparatus: 227   7  M [PKC ], 245   6  M
Figure 4. Ca
2  homeostasis in the ER 
lumen of control and PKC-overexpressing 
HeLa cells. Parallel batches of HeLa 
cells were either cotransfected with erAEQ 
and a PKC-GFP chimera including the 
indicated PKC isoform or transfected 
with erAEQ alone (control). 36 h after 
transfection, the Ca
2  stores were depleted 
of Ca
2  to optimize aequorin reconstitu-
tion as detailed in the text. After recon-
stitution, the cells were transferred to the 
luminometer chamber, and the ER store 
was refilled by switching the perfusion 
medium from KRB/EGTA to KRB/Ca
2 . 
Where indicated, the cells were perfused 
with 1 mM CaCl2 and challenged with 
100  M histamine.KC and Ca
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[PKC ], 246   7  M [PKC ], 257   10  M [PKC ],
and 217   6  M [PKC ]; n   6, P   0.05). To have a
complete picture of the Ca
2  handling properties of Ca
2 
stores, the basal Ca
2  leak from the ER was also investigated.
In these experiments, after aequorin reconstitution, the ER
was refilled with Ca
2  as described in the previous para-
graph. Then, the SERCA inhibitor 2,5-di-(tert-butyl)-1,4-
benzohydroquinone was added to the perfusion medium to
initiate passive Ca
2  efflux from the ER. No difference in
the leak rate between PKCs transfected and control cells was
observed (unpublished data).
Together, the aforementioned data indicate that the dif-
ferences previously observed in cellular Ca
2  homeostasis,
induced by overexpression of the different PKC isoforms,
are not due to changes in the filling state of the intracellular
Ca
2  stores. These results are particularly interesting (and
partially unexpected) in the case of PKC -overexpressing
cells, in which a very marked reduction of mitochondrial
and cytosolic responses to agonists had been observed.
We investigated the release phase (i.e., the [Ca
2 ]ER de-
crease occurring after agonist stimulation; Fig. 4). The rapid
[Ca
2 ]ER drop after histamine addition was larger (73   6
 M [PKC ] vs. 115  11  M [control]; n   9, P   0.05)
in control cells compared with PKC -transfected cells, indi-
cating a substantially reduced release through the IP3-gated
channels. These data are fully consistent with the cytosolic
and mitochondria reduction of Ca
2  responses and suggest a
direct, inhibitory effect on one of the components of the sig-
naling cascade from the plasma membrane receptor to the
Ca
2  release channels (i.e., from IP3 production to the activ-
ity of the IP3-gated channels).
On the contrary, with the other PKC isoforms, little or no
effect on Ca
2  release was observed: a small reduction in ER
Ca
2  release in PKC -transfected cells (85   6  M; n   9,
P   0.05) and no difference with all others isoforms (139  
10  M [PKC ], 129   13 [PKC ], and 118   8  M
[PKC ]; n   9, P   0.05). Similar results were obtained
from the analysis of the Golgi store. Also in this case, the
only significant effect was a smaller Ca
2  release in PKC -
overexpressing cells (Fig.5).
Together, these data show that although PKC  glo-
bally affects cellular Ca
2  signaling, the other isoforms (i.e.,
the  ,  , and  ) appear to modulate mitochondrial Ca
2  re-
sponses without significantly altering cellular Ca
2  homeo-
stasis, most likely acting directly on this organelle.
Mitochondrial membrane potential, ROS production, 
and organelle morphology in PKC-expressing cells
Next, the nature of this mitochondrial effect was investi-
gated. At first, we verified the occurrence of   m changes in
PKC-GFP–transfected and control cells. Using the   m-
sensitive dyes (TMRM and JC-1), no statistically significant
difference was detected between control and PKC-expressing
cells (identified by the GFP tag), although a small number of
cells with detectable   m decreases was observed upon
PKC  and   transfection. To be able to detect small
changes, we decided to measure free radical production
in mitochondria using the ROS-sensitive fluorescent probe
CM-H2DCFDA. ROS (ROS: O2
 *, H2O2, OH*) are gener-
ated from chemical reactions of molecular oxygen with the
enzymes and coenzymes of the respiratory chain. This pro-
cess is physiological and continuous (Skulachev, 1998), and
mitochondrial ROS production was shown to strictly depend
in a nonlinear way on   m. Indeed, even small   m de-
creases cause a large (measurable) inhibition of mitochondrial
ROS production, whereas   m increases cause a significant
stimulation of ROS production (Korshunov et al., 1997).
Thus, we performed single cell analysis of mitochondrial
ROS production in PKC-overexpressing cells. Mitochondrial
contribution was estimated by evaluating the effect of the
collapse of   m with FCCP on total ROS production, as de-
tailed in Materials and methods. Although a great variability
was observed between individual cells,  80% cells showed a
mitochondrial ROS production ranging between 10 and
40% of total cellular production. No significant difference
was detected upon overexpression of PKC  and  . Con-
Figure 5. Ca
2  homeostasis in the lumen 
of the Golgi apparatus of control and 
PKC-overexpressing HeLa cells. Parallel 
batches of HeLa cells were either cotrans-
fected with GoAEQ and a PKC-GFP 
chimera including the indicated PKC 
isoform or transfected with GoAEQ alone 
(Control). Aequorin reconstitution, 
experimental layout, and data display 
are as in Fig. 4. Where indicated, the 
cells were perfused with 1 mM CaCl2 
and challenged with 100  M histamine.228 The Journal of Cell Biology | Volume 165, Number 2, 2004
versely, mitochondrial ROS production appeared greatly de-
creased upon overexpression of PKC  and   ( 50 and 25%
of cells, respectively, compared with  10% of control cells,
had a mitochondrial ROS production  10%). Upon overex-
pression of PKC , mitochondrial ROS production was in-
creased ( 45% of PKC -expressing cells, compared with
 10% of control cells, had a mitochondrial ROS production
 50%). Although a   m change could not be directly
shown with TMRM, these data suggest that, in the case of
PKC , a small reduction in the driving force for Ca
2  accu-
mulation may occur, which could be in part responsible for
the reduction of mitochondrial Ca
2  accumulation.
Finally, we wished to rule out the possibility that the alter-
ation of mitochondrial Ca
2  responses was a consequence of
a major structural perturbation of the organelle (that could
cause the loss of the ER–mitochondria contacts, essential for
the large and prompt uptake of Ca
2  by mitochondria). Mi-
tochondrial structure was evaluated by labeling the organelle
with TMRM (that could be used in association with the
PKC-GFPs) and visualizing it with a confocal microscope.
Fig. 6 shows the mitochondrial fluorescence image obtained
from cells overexpressing the different PKC-GFP chimeras.
It is apparent that in all cases PKC overexpression caused no
obvious alteration in mitochondrial morphology, despite the
occurrence of occasional structural rearrangements both in
transfected and nontransfected cells.
PKC  is involved in the desensitization of mitochondrial 
Ca
2  uptake
A phenomenon that attracted much interest in the study of
mitochondrial Ca
2  signaling is the drastic reduction in am-
plitude occurring when two consecutive stimuli are applied.
Several factors contribute to this experimental observation:
(a) the second stimulation with the same agonist evokes a
smaller cytosolic response (due to receptor desensitization);
this response has a greater effect on mitochondrial Ca
2  ac-
cumulation, as shown in the experiment of Fig. 3 B. (b)
When aequorin is used for measuring [Ca
2 ]m, the higher
probe consumption (and depletion) in the mitochondrial re-
gions close to the ER may lead to an artifactual underestima-
tion of the following response (Rizzuto et al., 1998; Filippin
et al., 2003). However, evidence has been obtained that this
reduction, at least in part, represents a true desensitization of
the mitochondrial Ca
2  uptake machinery that has impor-
tant physiological consequences (e.g., an inhibition of events
that depend on mitochondrial Ca
2  accumulation, such as
insulin secretion; Maechler et al., 1998). The mechanism of
this inhibitory effects is still unknown, and we investigated
the possibility that the PKC isoforms, which are activated
upon agonist stimulation and specifically reduce the capacity
of mitochondria of accumulating Ca
2 , such as PKC ,
could be involved.
The working hypothesis was that if PKC  has a role in
desensitizing mitochondrial Ca
2  uptake, its inhibition dur-
ing the first histamine stimulation should lead to an increase
of the [Ca
2 ]m rise observed during the second agonist chal-
lenge. On the contrary, the second [Ca
2 ]c rise should not
be affected. Thus, the cells were treated with the specific in-
hibitor of PKC  hispidin (applied 1 min before the first ap-
plication of histamine, maintained throughout agonist stim-
ulation, and washed away). The results are shown in Fig. 7
B. The short treatment with the PKC  inhibitor does not
change the first response (consistent with the low PKC  ex-
pression in HeLa cells; Chun et al., 1996). On the contrary,
it markedly increases the [Ca
2 ]m peak evoked by the second
histamine stimulation (62   14  M vs. 38   8  M; n  
12, P   0.05), whereas no differences were observed in the
cytosolic response (2.3   0.6  M vs. 2.3   0.9  M; n   9,
P   0.05; Fig. 7 D). This potentiation of the second re-
sponse is due to a PKC -dependent desensitization (i.e., a
“long-term memory” of the first stimulation) and not to a
direct effect of the short treatment with the PKC inhibitor.
Indeed, the application of the PKC inhibitor by itself (e.g.,
not in coincidence with a first histamine stimulation) does
not modify the response to histamine applied 10 min after
the pulse with the inhibitor (Fig. 7 C, inset).
Given the confounding effect of the heterogeneous con-
sumption of the aequorin probe during the first stimulation,
we wished to confirm these results using a radically different
probe that is endowed with higher affinity (and thus could
Figure 6. Analysis of mitochondrial structure in PKC-overexpressing 
cells. HeLa cells were transfected with the PKC-GFP chimera 
including the indicated PKC isoform and loaded with 10 nM TMRM. 
Transfected cells were identified by visualizing GFP fluorescence 
(right), and mitochondrial structure was visualized with TMRM (left) 
as specified in Materials and methods. The field of cells is represen-
tative of  50 observations from at least 5 independent experiments.KC and Ca
2  homeostasis | Pinton et al. 229
underestimate the [Ca
2 ]m peak and small reductions in
[Ca
2 ]m responses) but is not consumed during repetitive ag-
onist stimulations. We used a mitochondrially targeted Cam-
garoo (mtCamgaroo-2), an insertional mutant of GFP sen-
sitive to Ca
2  (Griesbeck et al., 2001). HeLa cells were
transfected with mtCamgaroo-2, analyzed with an imaging
system based on a highly sensitive camera, and treated with
the double stimulation protocol used for the aequorin experi-
ments. With this mitochondrial Ca
2  probe, the second his-
tamine response is reduced to  18% (compared with the
first one) in control cells (n   18, P   0.05), whereas no dif-
ference in the mitochondrial response was detectable in the
presence of the PKC  inhibitor hispidin (n   16, P   0.05).
Discussion
PKCs comprise a closely related set of enzymes activated by
Ca
2  and/or diacylglycerol (i.e., second messengers produced
upon engagement of Gq-coupled plasma membrane recep-
tors; Mellor and Parker, 1998). Molecular diversity within the
PKC protein family (underlying different molecular targets
and mechanisms of activation) and/or specific tissue or subcel-
lular distribution of the isozymes make these Ca
2  transducers
a versatile toolkit, which allows stimulation of different recep-
tors to convert into very diverse cellular effects (Dekker et al.,
1995; Toker, 1998; Parekh et al., 2000; Shirai and Saito,
2002). For example, PKC  and   have been demonstrated to
have diametrically opposite effects on the process of apoptosis
(Ruvolo et al., 1998; Majumder et al., 2000).
However, PKC participates in Ca
2  signaling not only by
activating downstream effectors (enzymes, channels, and
transcription factors; Ben Ari et al., 1992; Jaken, 1996; Mos-
cat et al., 2003) but also by shaping the spatio-temporal
properties of the Ca
2  signal itself, highlighting a complex in-
terplay between the ion second messenger and its decoding
machinery. First, the changes in intracellular Ca
2  concentra-
tion and the timing of PKC activation were shown to exhibit
different kinetics. Oancea and Meyer (1998) showed that ac-
tivation of the Ca
2 -sensitive PKC  required the displace-
ment of an inhibitor pseudosubstrate; thus, PKC activation
(and ensuing cellular response) lagged behind agonist stimu-
lation. This observation implies that repetitive Ca
2  spikes
may be necessary for maximal PKC recruitment, and agonist
specific spiking frequencies (that can have results varying
from sustained PKC recruitment to no mobilization at all)
can be differentially decoded inside the cell (Oancea and
Meyer, 1998). Moreover, in an elegant paper, Mogami et al.
(2003) show how, in pancreatic   cells, the short-lived Ca
2 
signal is transduced via PKC activation into long-term phos-
phorylation of substrate with important implications for the
control of important phenomena such as insulin secretion.
Second, the Ca
2  response itself can be modified by a pre-
vious activation of PKC. This notion is supported by the
presence of consensus sequences for PKC phosphorylation
in important proteins related with Ca
2  homeostasis such as
the IP3 receptor (Willems et al., 1989; Nucifora et al.,
1995), the Ca
2  ATPase of the plasma membrane (Zylinska
et al., 1998), and several agonist receptors (Francesconi and
Duvoisin, 2000). This modulatory effect was recently dem-
onstrated by Montero et al. (2003), who showed that PKC
inhibition (through the use of a wide-spectrum blocker that
guaranteed the inhibition of all isozymes) drastically reduced
the agonist-dependent Ca
2  responses in HeLa cells. The
data clearly indicated a major role for PKC in tuning the in-
tensity of Ca
2  signals through an effect on the release kinet-
ics of the agonist-sensitive Ca
2  store.
In this work, we have investigated two main aspects. First,
we have separately analyzed the effect of various PKC iso-
forms belonging to different subgroups of the protein family
on the cellular Ca
2  signaling patterns. Second, we took ad-
vantage of organelle-specific Ca
2  probes (the targeted chi-
meras of the Ca
2 -sensitive photoprotein aequorin) to inves-
tigate if some PKC isoform can exert a specific effect on the
different Ca
2  pools, thus altering the cross talk between the
various reservoirs of this signaling ion. We devoted special
attention to mitochondria, which is an important decoding
checkpoint of Ca
2  signals (Duchen, 2000; Rizzuto et al.,
2000). Indeed, Ca
2  increases in the mitochondrial matrix,
Figure 7. Effect of PKC  inhibitor his-
pidin on the reduction of mitochondrial 
Ca
2  accumulation occurring upon 
repeated agonist stimulation. Mitochon-
drial (A and C) and cytosolic (B and D) 
[Ca
2 ] was monitored in PKC -overex-
pressing cells as in Fig. 1 and 3, respec-
tively. Where indicated, the cells were 
treated with 100  M histamine and 5  M 
hispidin (PKC  inhibitor).230 The Journal of Cell Biology | Volume 165, Number 2, 2004
which are triggered by agonist stimulation but also by apop-
totic agents such as ceramide, can induce, within the or-
ganelle, effects as diverse as stimulation of organelle metabo-
lism (Hajnoczky et al., 1995; Jouaville et al., 1999) and
morphological alterations, with the ensuing release of caspase
cofactors and the induction of apoptotic cell death (Szalai et
al., 1999; Pinton et al., 2001). Moreover, mitochondrial
Ca
2  uptake influences the properties of cytoplasmic Ca
2 
increases by either forming a firewall that prevents or delays
the spread of Ca
2  waves (Tinel et al., 1999) or rapidly clear-
ing Ca
2  at ER–mitochondria contacts, reducing the (posi-
tive or negative) feedback activity of Ca
2  on the ER release
channels (Hajnoczky et al., 1999). Finally, it was recently
proposed that Ca
2  release from mitochondria (through the
activation of the mitochondrial Na
 -Ca
2  exchanger) induces
a Ca
2  rise in presynaptic endings, which contributes to
posttetanic potentiation of neurotransmitters release (Yang
et al., 2003). For these reasons, the specific modulation of
the capacity of mitochondria to accumulate or release Ca
2 
(without affecting the global Ca
2  responses of the cell) can
greatly increase the flexibility of this signaling pathway.
The detailed analysis of the different PKC isoforms (ob-
tained by overexpressing a specific isozyme or inhibiting it
specifically in wild-type cells, two complementary approaches
that provided a coherent picture) revealed defined, differenti-
ated roles for the various members of the protein family. A
preliminary observation is that subunits belonging to the
same subgroup (e.g.,   and  , and   and  ) had very different
effects, indicating that PKC-dependent modulation of Ca
2 
signaling is based on the recruitment of highly specific sub-
strates or second messenger production patterns. In the case
of PKC , no alteration was observed in either the steady-state
[Ca
2 ] levels of resting cells or in the changes occurring upon
cell stimulation in any of the investigated compartments (ER,
Golgi apparatus, cytosol, and mitochondria), indicating that
the modulation of cellular Ca
2  signals is not a general prop-
erty shared by all PKC isoforms. In the case of PKC , a ma-
jor reduction was observed in the amplitude of Ca
2  re-
sponses induced by histamine stimulation. Although the
resting levels in the ER and Golgi Ca
2  stores were the same
of control cells, the drop in luminal [Ca
2 ] was much smaller,
and consequently the Ca
2  rises occurring in the cytosol and
in the mitochondria were significantly reduced. We have not
investigated where this desensitization of global Ca
2  signals
occurs (i.e., at the level of receptor, G protein, phospholipase
C, or IP3-receptor); however, we note that these results
closely match those of Montero et al. (2003), suggesting that
the increase of Ca
2  responses that they observe upon applica-
tion of wide-spectrum PKC inhibitors (Montero et al., 2003)
most likely reflects the inhibition of PKC .
However, the most surprising results were obtained with
PKC ,  , and  . Indeed, when the activity of these isoforms
was enhanced (by overexpression) or inhibited, the effect was
almost exclusively on mitochondrial Ca
2  uptake. Indeed,
although no significant alteration was detected in ER Ca
2 
release (and in the amplitude and kinetic properties of the
[Ca
2 ]c rise), mitochondrial [Ca
2 ] transients were reduced
by PKC   and   and increased by PKC  . Unfortunately, it
is very difficult to verify which is the molecular site of this
regulation, as the most plausible targets are still undefined at
the molecular level. Indeed, the Ca
2  transport system of the
inner mitochondrial membrane, characterized in terms of
biochemical properties (an electrogenic uniporter for accu-
mulation, an exchanger with Na
  or H
  for release), are still
unknown, and consequently no information is available also
on regulatory proteins that can interact with them and influ-
ence their activity. We have investigated whether or not the
alteration of mitochondrial Ca
2  responses could be indirect,
i.e., affecting either the three-dimensional structure of the
organelle (and thus the possibility of establishing close con-
tacts with the ER Ca
2  store [Rizzuto et al., 1998] that allow
fast Ca
2  accumulation into mitochondria) or the driving
force for the uptake of the cation (e.g., affecting the expres-
sion or activity of uncoupling proteins). On the former as-
pect, using TMRM to label the organelle, we observed no al-
teration of the three-dimensional mitochondrial network on
expression of any of the PKC isoforms used in our work. As
to the driving force, mitochondrial membrane potential was
directly measured with   m-sensitive dyes and indirectly as-
sessed through ROS production. No increase was detected
with the   isoform, nor decrease with the  , whereas a proba-
bly modest decrease in   m was detected in cells overex-
pressing the   isoforms. Thus, an indirect effect through
  m can be excluded in the former case, whereas it is possi-
ble that the sharp decrease of [Ca
2 ]m responses induced by
PKC  is in part mediated by a reduction of the driving force
for Ca
2  accumulation. Conversely, the primary effect of the
PKC , and most likely of PKC , appears to be on mitochon-
drial Ca
2  uptake, and its clarification awaits the molecular
definition of this important process.
Finally, we investigated if this regulatory mechanism could
be responsible for the well-known phenomenon of mitochon-
drial desensitization to repetitive agonist stimulation described
in cell systems as diverse as pancreatic  -cells (Nesher and
Cerasi, 1987; Anello et al., 1996; Kennedy et al., 1996) and
skeletal myotubes (Challet et al., 2001; whereas in HeLa cells
it was observed only in some experimental conditions [Collins
et al., 2001; Filippin et al., 2003]). In brief, a second stimula-
tion with an agonist causing a [Ca
2 ]c rise induces a drastically
reduced [Ca
2 ]m transient that cannot be fully accounted for
by receptor desensitization but must be ascribed to a reduced
Ca
2  uptake capacity of the organelle. This phenomenon was
shown to have important physiological implications, as it cor-
relates in pancreatic   cells with a major reduction in insulin
secretion (Maechler et al., 1998), but no information on the
possible mechanism was available. In this contribution, we
provide evidence that mitochondrial Ca
2  desensitization can
be ascribed to PKC isoforms that are activated by stimulation
of receptors coupled to the production of diacylglycerol and
IP3 (and thus cause a Ca
2  signal) and induce a reduction in
the capacity of mitochondria to rapidly accumulate Ca
2 . A
regulatory mechanism based on PKC-dependent phosphory-
lation can also explain the fact that in permeabilized cells such
a desensitization was not observed (Rizzuto et al., 1994), as in
this case cytosolic proteins, such as PKCs, are lost.
In conclusion, the results of this paper reveal specific roles
of the various PKC isoforms in shaping the Ca
2  signals
evoked by agonist stimulation in different Ca
2  pools and
cellular domains. In particular, the activity of defined PKC
isoforms was shown to modulate mitochondrial responses,KC and Ca
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while leaving global Ca
2  signals unaffected. Thus, mito-
chondria emerge as a “sink” of Ca
2  released from the ER or
entering through plasma membrane channels endowed with
unique properties. On the one hand, they participate in de-
coding Ca
2 -linked agonist stimulations (through intra- and
extramitochondrial effects); on the other hand, they can vary
their response based on the convergence of PKC-mediated
(and possibly other) signaling pathways. Although future
work will address the molecular targets of this regulatory
mechanism, these results may already highlight novel phar-
macological routes for specifically modifying Ca
2 -depen-
dent cellular dysfunctions that occur in a variety of genetic
and acquired human disorders.
Materials and methods
Cell culture and transfection
HeLa cells were grown in DME supplemented with 10% FCS in 75 cm
2
Falcon flasks. For aequorin measurements, the cells were seeded before
transfection onto 13-mm glass coverslips and allowed to grow to 50% con-
fluence. At this stage, transfection with 4  g of plasmid DNA (control cells:
3  g mtGFP   1  g AEQ; PKC-overexpressing cells: 3  g PKC-GFP chi-
mera of interest   1  g AEQ) was performed as described previously (Riz-
zuto et al., 1995) and aequorin measurements were performed 36 h after
transfection. For   m, ROS production, and fura-2 measurements, the
cells (seeded onto 24-mm coverslips) were transfected with 8  g PKC-GFP
plasmid. For single cells [Ca
2 ]m measurements, HeLa cells were seeded
onto 24-mm coverslips and transfected with 8  g mtCamgaroo-2 (Gries-
beck et al., 2001).
Aequorin measurements
For cytosolic aequorin (cytAEQ) and mitochondrial aequorin (mtAEQ)
measurements, the coverslip with the cells was incubated with 5  M coe-
lenterazine for 1–2 h in DME supplemented with 1% FCS and transferred
to the perfusion chamber. For reconstituting with high efficiency the ae-
quorin chimeras targeted to the Golgi apparatus and the ER (GoAEQ and
erAEQ, respectively), the luminal [Ca
2 ] of these compartments must first
be reduced. This result was obtained by incubating the cells for 1 h at 4 C
in KRB (Krebs-Ringer modified buffer: 125 mM NaCl, 5 mM KCl, 1 mM
Na3PO4, 1 mM MgSO4, 5.5 mM glucose, and 20 mM Hepes, pH 7.4, at
37 C) supplemented with 5  M ionomycin and 600  M EGTA in the pres-
ence of 5  M coelenterazine n. After this incubation, the cells were exten-
sively washed with KRB supplemented with 2% BSA and 1 mM EGTA. All
aequorin measurements were performed in KRB supplemented with 1 mM
CaCl2 (KRB/Ca
2 ). Agonists and other drugs were added to the same me-
dium, as specified in the figure legends. The experiments were terminated
by lysing the cells with 100  M digitonin in a hypotonic Ca
2 -rich solution
(10 mM CaCl2 in H2O), thus discharging the remaining aequorin pool. The
light signal was collected and calibrated into [Ca
2 ] values as described
previously (Brini et al., 1995; Barrero et al., 1997). All the results are ex-
pressed as means   SEM.
Measurements of   m, ROS production, and microscopic 
analysis of mitochondrial structure
ROS production in control and PKC-transfected cells was measured with
the ROS-sensitive fluorescent probe 5- (and 6)-chloromethyl-2’,7’-dichlo-
rohydrofluoresceindiacetate (CM-H2DCFDA). The acetate group of CM-
H2DCFDA is hydrolyzed by esterases inside the cell and it is trapped as a
nonfluorescent probe (CM-H2DCF). Then, ROS increases its fluorescence.
Cells were incubated with 2  M CM-H2DCFDA for 20 min and washed
with KRB/Ca
2 . The green emission of CM-DCF was recorded at 520 nm.
Acquisitions were made every 1 s (exposure time 100–200 ms). After a few
minutes, when the rate of free radical production was constant, 300 nM
FCCP was added to depolarize mitochondria (drastically reducing mito-
chondrial ROS production), and the measurements were continued for a
few other minutes. The difference between the rates of ROS production be-
fore and after FCCP addition reflected the mitochondrial contribution to cel-
lular ROS production (expressed as a percentage of total production). Im-
ages were recorded using a digital imaging system based on a fluorescence
microscope (model Axiovert 200; Carl Zeiss MicroImaging, Inc.) equipped
with a back-illuminated CCD camera (Roper Scientific), excitation and
emission filterwheels (Sutter Instrument Company), and piezoelectric motor-
ing of the z stage (Physik Instrumente; GmbH & Co.). The data were ac-
quired and processed using the MetaFluor analyzing program (Universal Im-
aging Corp.).   m was measured using 10 nM TMRM on a confocal
microscope (model LSM 510; Carl Zeiss MicroImaging, Inc.). The signal was
collected as total emission  570 nm. To distinguish control from PKC-GFP–
transfected cells, green emission was collected in the range  505– 535
nm. Mitochondrial structure of control and PKC-transfected cells was stud-
ied on a confocal microscope after loading 10 nM TMRM. Red and green
signals (visualizing mitochondrial structure and identifying transfected cells,
respectively) were collected as described in the previous paragraph.
Fura-2 measurements
The coverslip with PKC-transfected HeLa cells was incubated with 5  M
fura-2 (added to DME   1% FCS) at 37 C for 30 min. After a brief wash
with KRB/Ca
2 , they were placed in an open Leyden chamber on the ther-
mostated stage of an inverted microscope (model Axiovert; Carl Zeiss Mi-
croImaging, Inc.) equipped with a Sutter filterwheel and 340/380 excita-
tion filters. The fluorescence data were collected with a back-illuminated
camera (Princeton Instruments) and expressed as emission ratios using the
Metafluor software (Universal Imaging Corp.). Within the microscope
field, transfected and untransfected cells were identified before carrying
out the fura-2 monitoring by revealing the fluorescence of mtGFP, cotrans-
fected with the PKC isoform of interest.
[Ca
2 ] measurements with mtCamgaroo-2
The coverslip with the mtCamgaroo-2–transfected cells were placed in an
open Leyden chamber on the thermostated stage of an inverted micro-
scope equipped with a Sutter filterwheel. The fluorescence data were col-
lected with a back-illuminated camera using the Metafluor software. The
time of illumination was reduced to a minimum (50 ms) and at least 1 s be-
tween two successive illuminations were allowed to avoid the well-known
phenomenon of photoconversion of the probe into a form almost com-
pletely insensitive to Ca
2  changes, as reported by Filippin et al. (2003).
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